Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer

Purpose: High-risk (HR) prostate cancer patients usually receive high-dose radiotherapy (RT) using a two-phase sequential technique, but data on a simultaneous integrated boost (SIB) technique are lacking. We prospectively evaluated the long-term results of urinary (GU) and digestive (GI) toxicity a...

Full description

Bibliographic Details

Published in:	Clinical and Translational Radiation Oncology
Main Authors:	Ingrid Masson, Laurène Larriviere, Marc-André Mahé, David Azria, Pascal Pommier, Nathalie Mesgouez-Nebout, Philippe Giraud, Didier Peiffert, Bruno Chauvet, Philippe Dudouet, Naji Salem, Georges Noël, Jonathan Khalifa, Igor Latorzeff, Catherine Guérin-Charbonnel, Stéphane Supiot
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630823001271